LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $488,000 | -0.2% | 16,392 | 0.0% | 0.06% | +14.6% |
| Q1 2017 | $489,000 | -42.6% | 16,392 | -69.2% | 0.05% | -57.5% |
| Q2 2016 | $852,000 | -26.7% | 53,254 | -4.2% | 0.11% | -19.9% |
| Q1 2016 | $1,163,000 | -3.2% | 55,600 | +25.0% | 0.14% | -6.0% |
| Q4 2015 | $1,201,000 | +262.8% | 44,463 | +273.6% | 0.15% | +233.3% |
| Q3 2015 | $331,000 | – | 11,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |